Amber Ophthalmics
CA - San DiegoBiotechnology
Focus: Amber Ophthalmics is a San Diego-based biotech focused on novel therapeutics for rare anterior segment ophthalmic diseases. The company operates at pre-revenue stage with a lean pipeline centered on corneal regeneration.
Profile data last refreshed 9h ago · AI intelligence enriched 3w ago
Open Jobs
22-3 this month
Stable — net -3 jobs in 30d
15 added, 18 removed. Backfill posture.
Should You Work at Amber Ophthalmics?
AI assessmentAmber Ophthalmics offers rare-disease focus and early-stage exposure, but limited pipeline depth and unusual commercial-to-R&D hiring ratio warrant due diligence on funding runway and Nexagon clinical momentum before committing.
Why Work Here
- Focused therapeutic area (rare anterior segment ophthalmology) offers deep specialization and meaningful clinical impact in an underserved niche.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 2
Clinical Trials (1)
NCT04081103NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries
Phase 2Help build intelligence for Amber Ophthalmics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.